Comparison of the anaesthetic effects of remimazolam besylate and remimazolam tosilate in day surgery for hysteroscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400081688

Enrollment

Unknown

Registered

2024-03-08

Start date

2024-03-15

Completion date

Unknown

Last updated

2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

RB group: remimazolam besylate

RT group: remimazolam tosilate

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients undergoing elective hysteroscopic day surgery, ASAI-II, aged 18-65 years were selected.

Exclusion criteria

Exclusion criteria: 1. Patients with allergies to drugs such as remazolam; 2. patients with addiction to sedative drugs and alcohol 3. patients with severe hepatic or renal dysfunction or history of severe cardiovascular disease; 4. patients with hearing abnormalities; 5. patients with cognitive dysfunction and low obedience.

Design outcomes

Primary

Measure	Time frame
Induction of anaesthesia with remimazolam;	—

Secondary

Measure	Time frame
awakening time;Time to loss of patient's consciousness;Maintenance of anaesthesia;Incidence of adverse events during anaesthesia;	—

Countries

China

Contacts

Public ContactJi Fanceng

Weifang People's Hospital

jifanceng@163.com+86 135 6369 8838

Outcome results